These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

838 related items for PubMed ID: 26690371

  • 1. Targeting STAT3/miR-21 axis inhibits epithelial-mesenchymal transition via regulating CDK5 in head and neck squamous cell carcinoma.
    Sun SS, Zhou X, Huang YY, Kong LP, Mei M, Guo WY, Zhao MH, Ren Y, Shen Q, Zhang L.
    Mol Cancer; 2015 Dec 21; 14():213. PubMed ID: 26690371
    [Abstract] [Full Text] [Related]

  • 2. microRNA-203 suppresses invasion and epithelial-mesenchymal transition induction via targeting NUAK1 in head and neck cancer.
    Obayashi M, Yoshida M, Tsunematsu T, Ogawa I, Sasahira T, Kuniyasu H, Imoto I, Abiko Y, Xu D, Fukunaga S, Tahara H, Kudo Y, Nagao T, Takata T.
    Oncotarget; 2016 Feb 16; 7(7):8223-39. PubMed ID: 26882562
    [Abstract] [Full Text] [Related]

  • 3. WP1066 sensitizes oral squamous cell carcinoma cells to cisplatin by targeting STAT3/miR-21 axis.
    Zhou X, Ren Y, Liu A, Jin R, Jiang Q, Huang Y, Kong L, Wang X, Zhang L.
    Sci Rep; 2014 Dec 17; 4():7461. PubMed ID: 25514838
    [Abstract] [Full Text] [Related]

  • 4. STAT3 inhibitor WP1066 attenuates miRNA-21 to suppress human oral squamous cell carcinoma growth in vitro and in vivo.
    Zhou X, Ren Y, Liu A, Han L, Zhang K, Li S, Li P, Li P, Kang C, Wang X, Zhang L.
    Oncol Rep; 2014 May 17; 31(5):2173-80. PubMed ID: 24676554
    [Abstract] [Full Text] [Related]

  • 5. TGF-β-induced STAT3 overexpression promotes human head and neck squamous cell carcinoma invasion and metastasis through malat1/miR-30a interactions.
    Wang Y, Wu C, Zhang C, Li Z, Zhu T, Chen J, Ren Y, Wang X, Zhang L, Zhou X.
    Cancer Lett; 2018 Nov 01; 436():52-62. PubMed ID: 30118844
    [Abstract] [Full Text] [Related]

  • 6. AC1MMYR2 impairs high dose paclitaxel-induced tumor metastasis by targeting miR-21/CDK5 axis.
    Ren Y, Zhou X, Yang JJ, Liu X, Zhao XH, Wang QX, Han L, Song X, Zhu ZY, Tian WP, Zhang L, Mei M, Kang CS.
    Cancer Lett; 2015 Jul 01; 362(2):174-82. PubMed ID: 25827073
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. PRRX1 Regulates Cellular Phenotype Plasticity and Dormancy of Head and Neck Squamous Cell Carcinoma Through miR-642b-3p.
    Jiang J, Zheng M, Zhang M, Yang X, Li L, Wang SS, Wu JS, Yu XH, Wu JB, Pang X, Tang YJ, Tang YL, Liang XH.
    Neoplasia; 2019 Feb 01; 21(2):216-229. PubMed ID: 30622052
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. CSC-3436 inhibits TWIST-induced epithelial-mesenchymal transition via the suppression of Twist/Bmi1/Akt pathway in head and neck squamous cell carcinoma.
    Lai YJ, Yu WN, Kuo SC, Ho CT, Hung CM, Way TD, Chen CT.
    J Cell Physiol; 2019 Jun 01; 234(6):9118-9129. PubMed ID: 30341909
    [Abstract] [Full Text] [Related]

  • 14. Targeting miR-21 with Sophocarpine Inhibits Tumor Progression and Reverses Epithelial-Mesenchymal Transition in Head and Neck Cancer.
    Liu W, Zhang B, Chen G, Wu W, Zhou L, Shi Y, Zeng Q, Li Y, Sun Y, Deng X, Wang F.
    Mol Ther; 2017 Sep 06; 25(9):2129-2139. PubMed ID: 28571917
    [Abstract] [Full Text] [Related]

  • 15. Inflammatory mediators drive metastasis and drug resistance in head and neck squamous cell carcinoma.
    St John MA.
    Laryngoscope; 2015 Mar 06; 125 Suppl 3():S1-11. PubMed ID: 25646683
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. MicroRNA-204-5p is a tumor suppressor and potential therapeutic target in head and neck squamous cell carcinoma.
    Zhuang Z, Yu P, Xie N, Wu Y, Liu H, Zhang M, Tao Y, Wang W, Yin H, Zou B, Hou J, Liu X, Li J, Huang H, Wang C.
    Theranostics; 2020 Mar 06; 10(3):1433-1453. PubMed ID: 31938073
    [Abstract] [Full Text] [Related]

  • 20. miR-204 inhibits angiogenesis and promotes sensitivity to cetuximab in head and neck squamous cell carcinoma cells by blocking JAK2-STAT3 signaling.
    Wu Q, Zhao Y, Wang P.
    Biomed Pharmacother; 2018 Mar 06; 99():278-285. PubMed ID: 29353201
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.